Nuvectis Pharma, Inc. (NVCT)

19.01 +0.41 (+2.20%) USD  |  NASDAQ  |  Oct 19, 15:52
More

Nuvectis Pharma EV to Revenues

EV to Revenues Chart

View EV to Revenues for NVCT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to Revenues Data

View and export this data back to . Start Trial.
Date Value

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
Opus Genetics, Inc. Upgrade
Faeth Therapeutics, Inc. --
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade

EV to Revenues Related Metrics

EV to CFO Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade